Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 134 of the 135 references it cites were found in a registry or an index.

Advances in the design and development of chemical modulators of the voltage-gated potassium channels K V 7.4 and K V 7.5

Open access
Lemke, Jana, Gollasch, Maik, Tsvetkov, Dmitry, Schulig, Lukas · 2025 · Expert Opinion on Drug Discovery

Abstract

Introduction Hypertension remains a major public health concern, with significant morbidity and mortality worldwide. Despite the availability of various antihypertensive medications, blood pressure control remains suboptimal in many individuals. During the last decades, KV7.4 and KV7.5, which were already known from the view of neuronal regulation, emerged as possible important players in the regulation of vascular tone and blood pressure.Areas covered This review covers physiological functions and current advancements in the development of KV7.4 and KV7.5 channel modulators. The authors highlight the structural elements likely to be important for the future design of KV7subtype-selective modulators, underscoring their potential as an innovative hypertension treatment.Expert opinion Extensive research has been focused on targeting neuronal KV7.2 and KV7.3 channels, while KV7.4 and KV7.5 attracted less attention. Many of the developed compounds represent derivatives of flupirtine or retigabine, whereby subtype channel selectivity has only been demonstrated for a handful of individual compounds. Novel substances address additional sites within the binding pocket by incorporating new functional groups. A comprehensive and systematic evaluation of a compound set with significant subtype selectivity should be performed. The discovery of new highly active, less toxic, and selective compounds, therefore, remains the goal of further research in the coming years.

Overview

Integrity signals

Registry

Crossref · 10.1080/17460441.2024.2438226

Cites

134 of 134 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 135 references

Research works printed but not linked: 3

  1. 10.1111/micc.12434 · DOI
  2. 10.1124/mol.58.2.253 · doi:10.1124/mol.58.2.253 · Paper page
  3. Yu H, Wu M, Hopkins C, et al. A small molecule activator of KCNQ2 and KCNQ4 channels. In: Probe reports from the NIH molecular libraries program. Bethesda (MD): National Center for Biotechnology Information (US); 2010.

Cited by

See all 6

Metadata

Authors
Lemke, J., Gollasch, M., Tsvetkov, D., & Schulig, L.
Affiliations
  • Universität Greifswald (DE)
  • Universitätsmedizin Greifswald (DE)
Corresponding author
Schulig, Lukas
Venue
Expert Opinion on Drug Discovery
Published
2024-12-09
Volume
20
Issue
1
Pages
47-62
ISSN
  • 1746-0441 (ISSN-L)
  • 1746-045X
OpenAlex
W4405020509
Cited by
6
References
135
Citations by year
2026: 2 · 2025: 4
FWCI
0.24
Type
journal article
Language
en
Open access
Locations
  • Expert Opinion on Drug Discovery (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
Deutsche Forschungsgemeinschaft (GO766/12–3, GO766/15–2, GO766/22–3, SFB 1365)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
Kv7.4, Kv7.5, voltage-gated potassium channels, channel modulators, hypertension, blood pressure regulation, vascular tone, drug design, potassium channel structure
MeSH terms
Animals, Antihypertensive Agents, Blood Pressure, Carbamates, Humans, Hypertension, Phenylenediamines, Drug Design, KCNQ Potassium Channels

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Advances in the design and development of chemical modulators of the voltage-gated potassium channels K V 7.4 and K V 7.5. https://app.cochat.ai/papers/10.1080/17460441.2024.2438226
The paper
Lemke, J., Gollasch, M., Tsvetkov, D., & Schulig, L. (2025). Advances in the design and development of chemical modulators of the voltage-gated potassium channels K V 7.4 and K V 7.5. Expert Opinion on Drug Discovery. https://doi.org/10.1080/17460441.2024.2438226

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.